Terms: = Endocrine gland cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Prognosis
111 results:
1. Machine learning developed a fibroblast-related signature for predicting clinical outcome and drug sensitivity in ovarian cancer.
Fu W; Feng Q; Tao R
Medicine (Baltimore); 2024 Apr; 103(16):e37783. PubMed ID: 38640321
[TBL] [Abstract] [Full Text] [Related]
2. Machine learning developed a CD8
Chen R; Zheng Y; Fei C; Ye J; Fei H
Sci Rep; 2024 Mar; 14(1):5794. PubMed ID: 38461331
[TBL] [Abstract] [Full Text] [Related]
3. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer.
Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y
Front Immunol; 2024; 15():1228235. PubMed ID: 38404588
[TBL] [Abstract] [Full Text] [Related]
4. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
[TBL] [Abstract] [Full Text] [Related]
6. Machine Learning Developed a Programmed Cell Death Signature for Predicting prognosis, Ecosystem, and Drug Sensitivity in Ovarian cancer.
Wang L; Chen X; Song L; Zou H
Anal Cell Pathol (Amst); 2023; 2023():7365503. PubMed ID: 37868825
[TBL] [Abstract] [Full Text] [Related]
7. S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study.
Hao W; Zhang Y; Dou J; Cui P; Zhu J
BMC Cancer; 2023 Oct; 23(1):997. PubMed ID: 37853345
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning developed a PI3K/Akt pathway-related signature for predicting prognosis and drug sensitivity in ovarian cancer.
Han X; Yang L; Tian H; Ji Y
Aging (Albany NY); 2023 Oct; 15(20):11162-11183. PubMed ID: 37851341
[TBL] [Abstract] [Full Text] [Related]
9. Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE
De Monte L; Clemente F; Ruggiero E; Pini R; Ceraolo MG; Schiavo Lena M; Balestrieri C; Lazarevic D; Belfiori G; Crippa S; Balzano G; Falconi M; Doglioni C; Bonini C; Reni M; Protti MP
EBioMedicine; 2023 Nov; 97():104819. PubMed ID: 37776595
[TBL] [Abstract] [Full Text] [Related]
10. Establishment and validation of an immune infiltration predictive model for ovarian cancer.
Song Z; Zhang J; Sun Y; Jiang Z; Liu X
BMC Med Genomics; 2023 Sep; 16(1):227. PubMed ID: 37759229
[TBL] [Abstract] [Full Text] [Related]
11. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
[TBL] [Abstract] [Full Text] [Related]
12. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
13. A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance.
Chen L; Gao W; Lin L; Sha C; Li T; Chen Q; Wei H; Yang M; Xing J; Zhang M; Zhao S; Xu W; Li Y; Long L; Zhu X
J Ovarian Res; 2023 Sep; 16(1):186. PubMed ID: 37674251
[TBL] [Abstract] [Full Text] [Related]
14. Molecular features, biological behaviors and clinical implications of m
Zhan M; Song H; Tian D; Wen Q; Shi X; Wang Y; Mao X; Wang J
Cancer Biol Ther; 2023 Dec; 24(1):2223382. PubMed ID: 37332118
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of characteristics of four patients with adrenal unicentric Castleman disease.
Yu H; Wang Y; Li Y; Du J; Guo Q; Gu W; Lyu Z; Dou J; Mu Y; Zang L
Front Endocrinol (Lausanne); 2023; 14():1181929. PubMed ID: 37265694
[TBL] [Abstract] [Full Text] [Related]
16. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the prognosis and Immune Microenvironment of Patients with Pancreatic cancer.
Zou T; Shi D; Wang W; Chen G; Zhang X; Tian Y; Gong P
Mediators Inflamm; 2023; 2023():5565054. PubMed ID: 37181810
[TBL] [Abstract] [Full Text] [Related]
17. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
[TBL] [Abstract] [Full Text] [Related]
18. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
[TBL] [Abstract] [Full Text] [Related]
19. The specific phagocytosis regulators could predict recurrence and therapeutic effect in thyroid cancer: A study based on bioinformatics analysis.
Hou C; Wu M; Zhang H; Yang Z
Medicine (Baltimore); 2023 Mar; 102(11):e33290. PubMed ID: 36930113
[TBL] [Abstract] [Full Text] [Related]
20. Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic cancer.
Kano MT; Kokuryo T; Baba T; Yamazaki K; Yamaguchi J; Sunagawa M; Ogura A; Watanabe N; Onoe S; Miyata K; Mizuno T; Uehara K; Igami T; Yokoyama Y; Ebata T; Nagino M
Anticancer Res; 2023 Mar; 43(3):1009-1016. PubMed ID: 36854520
[TBL] [Abstract] [Full Text] [Related]
[Next]
